These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 98692)
1. [Contribution of drug therapy to the efficiency in health care delivery]. Rathscheck R Med Klin; 1978 Aug; 73(32-33):1152-4. PubMed ID: 98692 [No Abstract] [Full Text] [Related]
2. [Economic criteria for covering medical interventions by the German Public Health Insurance]. Grell L Med Klin (Munich); 2000 Jun; 95 Suppl 1():18-20. PubMed ID: 10941249 [TBL] [Abstract][Full Text] [Related]
3. [Usefulness of new drugs]. MMW Munch Med Wochenschr; 1980 Jan; 122(1):28-9. PubMed ID: 6767916 [No Abstract] [Full Text] [Related]
5. [The value of EEG studies in correlation to vaccinations]. Kasper JM; Wässer S Z Arztl Fortbild (Jena); 1978 May; 72(10):457-61. PubMed ID: 354242 [No Abstract] [Full Text] [Related]
6. Drug therapy often cost-effective. Arkinstall WW CMAJ; 1996 Sep; 155(5):512. PubMed ID: 8804254 [No Abstract] [Full Text] [Related]
7. [Immunizations up-to-date for Switzerland (author's transl)]. Just M Ther Umsch; 1979 Sep; 36(9):812-8. PubMed ID: 505331 [No Abstract] [Full Text] [Related]
8. Benefits, risks and costs of viral vaccines. Koplan JP; Axnick NW Prog Med Virol; 1982; 28():180-91. PubMed ID: 6806868 [No Abstract] [Full Text] [Related]
9. Childhood immunoprophylaxis: achievements in a Glasgow practice. Ross SK Health Bull (Edinb); 1983 Sep; 41(5):253-7. PubMed ID: 6643044 [No Abstract] [Full Text] [Related]
11. [Investing in health care with Dekker as a guide]. Boer EJ Ned Tijdschr Geneeskd; 1989 Nov; 133(46):2296-300. PubMed ID: 2586655 [No Abstract] [Full Text] [Related]
12. [Survey on vaccination antecedents and immunity levels in a children population of 1 to 4 years of age in the state of Tlaxcala]. Aburto Galván C Salud Publica Mex; 1977; 19(3):325-33. PubMed ID: 594832 [No Abstract] [Full Text] [Related]
13. Advice for travelers. Med Lett Drugs Ther; 1999 Apr; 41(1051):39-42. PubMed ID: 10368704 [No Abstract] [Full Text] [Related]
14. Cost-effectiveness of genotyping to guide treatment. Sorich MJ; Wiese MD; Pekarsky B Pharmacogenomics; 2014 Apr; 15(6):727-9. PubMed ID: 24897279 [No Abstract] [Full Text] [Related]
15. [Cost-benefit analysis in measles and mumps vaccinations]. Wiedermann G; Ambrosch F Wien Med Wochenschr; 1978 Feb; 128(3):73-6. PubMed ID: 415440 [No Abstract] [Full Text] [Related]
16. [Costs and benefits of measles vaccination]. Ambrosch F; Wiedermann G; Harasek G Fortschr Med; 1978 Feb; 96(8):409-14. PubMed ID: 415953 [TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of alternative polio immunization policies in South Africa. Griffiths UK; Botham L; Schoub BD Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096 [TBL] [Abstract][Full Text] [Related]
18. The chief scientist reports ... using economic appraisal in health services research. Ludbrook A Health Bull (Edinb); 1990 Mar; 48(2):81-90. PubMed ID: 2110122 [No Abstract] [Full Text] [Related]
19. Recent developments in immunization. Fedson DS Prim Care; 1979 Mar; 6(1):169-94. PubMed ID: 223185 [No Abstract] [Full Text] [Related]
20. Health policy uses and usefulness of cost-benefit and cost-effectiveness analysis. Warner KE Mead Johnson Symp Perinat Dev Med; 1982; (20):53-69. PubMed ID: 6821470 [No Abstract] [Full Text] [Related] [Next] [New Search]